Chemokines and Chemokine Receptors in Neurological Disease: Raise, Retain, or Reduce?

Abstract

Summary:Chemokines and chemokine receptors comprise a large number of molecules implicated in a wide range of physiological and pathological functions. Numerous studies have demonstrated the roles of chemokines and chemokine receptors: 1) during development, by regulating hematopoiesis, cardiogenesis, and vascular and cerebellar development; 2) during tumor biology, by controlling cell proliferation, angiogenesis, and metastasis; and 3), especially during leukocyte migration, by acting on firm adhesion, locomotion, diapedesis, and chemotaxis. This review focuses on chemokine and chemokine receptor involvement in diverse neurological diseases and their therapeutic potentials. Because of its induction or upregulation during CNS pathologies, members of the chemokine system can be used as biological markers. CXCR4 and CXCL12, by the correlation between their expression and the glioblastoma tumor progression, could be a marker to grade this type of CNS tumor. CCR1, by virtue of specific expression in A␤ plaques, may be a marker for Alzheimer pathology. Downregulation of CCL2 in cerebrospinal fluid may be a candidate to characterize multiple sclerosis (MS), but needs additional investigation. Moreover, chemokines and chemokine receptors represent interesting therapeutic targets. Using chemokine receptor antagonists, several studies provided exciting findings for potential neurological disease treatment. Chemokine receptor antagonists reduce disease severity in animal models of MS. In glioblastoma, a CXCR4 antagonist (AMD3100) showed an inhibition of tumor growth. Inhibition of chemokine receptor signaling is not the only therapeutic strategy: for example, CXCR4 -CXCL12 has anti-inflammatory properties and CX3CL1-CX3CR1 controls neurotoxicity. Thus, chemokine biology suggests several approaches for treating neurological disease.

CXCL16 Orchestrates Adenosine A3Receptor and MCP-1/CCL2 Activity to Protect Neurons from Excitotoxic Cell Death in the CNS

“…The target of CCL2, involved in mediating the neuroprotective activity of the chemokine, has not been addressed in the present study: previous reports showed that the main receptor for CCL2 is CCR2, but this chemokine can also bind to other receptors like CCR1, CCR4, and L-CCR, albeit with lower affinity Savarin-Vuaillat et al, 2007;White et al, 2007;Quinones et al, 2008). In addition, CCR2 expression in brain parenchyma is controversial.…”

Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction

“…Exogenous FGF caused a 62% increase in the overall number of dividing cells (10). SDF-1␣ and its G protein-coupled receptor CXCR4 are also implicated in cardiogenesis (25). Aurora B kinase is a key regulator of chromosome segregation during mitosis (11).…”

Inflammation in Alzheimer’s Disease and Molecular Genetics: Recent Update

“…These secreted inflammatory mediators, in turn, activate more microglia and astrocytes to produce inflammatory molecules. In addition, immune cells including, T cells, B cells and monocytes are found to migrate from the periphery through the BBB and present in the brains of AD individuals (Conductier et al 2010;Ruan et al 2010;Savarin-Vuaillat and Ransohoff 2007).…”